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In Brief
For decades, the omentum has been
known as the policeman of the abdomen.
Jackson-Jones et al. reveal the existence
of specialized mesothelial cells within fat-
associated lymphoid clusters of the
omentum that are responsible for the
capture of peritoneal contaminants via
the formation of neutrophil aggregates,
preventing systemic spread.
Immunity
ArticleStromal Cells Covering Omental Fat-Associated
Lymphoid Clusters Trigger Formation of Neutrophil
Aggregates to Capture Peritoneal Contaminants
Lucy Helen Jackson-Jones,1,2,* Peter Smith,1 Jordan Raymond Portman,3 Marle`ne Sophie Magalhaes,1
Katie Jude Mylonas,1,3 Matthieu Marie Vermeren,4 Mark Nixon,1 Beth Emily Pollot Henderson,3 Ross Dobie,3
Sonja Vermeren,3 Laura Denby,1 Neil Cowan Henderson,3,5 Damian James Mole,3 and Ce´cile Be´ne´zech1,6,*
1Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK
2Division of Biomedical and Life Sciences, Lancaster University, Lancaster LA1 4YQ, UK
3Centre for Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK
4Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4TJ, UK
5MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
6Lead Contact
*Correspondence: l.jackson-jones@lancaster.ac.uk (L.H.J.-J.), cbenezec@ed.ac.uk (C.B.)
https://doi.org/10.1016/j.immuni.2020.03.011SUMMARY
The omentum is a visceral adipose tissue rich in fat-
associated lymphoid clusters (FALCs) that collects
peritoneal contaminants and provides a first layer
of immunological defense within the abdomen.
Here, we investigated the mechanisms that mediate
the capture of peritoneal contaminants during perito-
nitis. Single-cell RNA sequencing and spatial anal-
ysis of omental stromal cells revealed that the sur-
face of FALCs were covered by CXCL1+ mesothelial
cells, which we termed FALC cover cells. Blockade
of CXCL1 inhibited the recruitment and aggregation
of neutrophils at FALCs during zymosan-induced
peritonitis. Inhibition of protein arginine deiminase
4, an enzyme important for the release of neutrophil
extracellular traps, abolished neutrophil aggregation
and the capture of peritoneal contaminants by
omental FALCs. Analysis of omental samples from
patients with acute appendicitis confirmed neutro-
phil recruitment and bacterial capture at FALCs.
Thus, specialized omental mesothelial cells coordi-
nate the recruitment and aggregation of neutrophils
to capture peritoneal contaminants.
INTRODUCTION
The omentum, a visceral fat depot contained within a fold of peri-
toneum, has the capacity to rapidly absorb particles and patho-
gens present in the peritoneal cavity (Meza-Perez and Randall,
2017; Platell et al., 2000). The omentum has important immuno-
logical properties derived from the presence of numerous im-
mune cell clusters called fat-associated lymphoid clusters
(FALCs; Rangel-Moreno et al., 2009), which are also found in
the mesentery (Moro et al., 2010), the mediastinum, and pericar-
dium, in association with the peritoneal, pleural, and pericardial700 Immunity 52, 700–715, April 14, 2020 ª 2020 The Author(s). Pub
This is an open access article under the CC BY license (http://creativecavities (Be´ne´zech et al., 2015; Jackson-Jones et al., 2016).
The continuous flow of fluid from the peritoneal cavity through
omental (om)FALCsmakes them unique niches for the clearance
of peritoneal contaminants and initiation of protective immune
responses during peritonitis.
FALCs support multifaceted stromal-immune cell interactions,
which are critical for the maintenance and function of innate-like
B cells (IBCs) within the serous cavities, as well as facilitating
T-cell-dependent B cell immune responses to peritoneal anti-
gens (Ansel et al., 2002; Be´ne´zech et al., 2015; Rangel-Moreno
et al., 2009). FALC stromal cells produce the chemokine
CXCL13, which maintains peritoneal IBCs (Ansel et al., 2002;
Be´ne´zech et al., 2015; Rangel-Moreno et al., 2009). Upon inflam-
matory signals, serous B cells migrate into FALCs where the pro-
vision of interleukin (IL)-5 by type 2 innate lymphocytes (ILC2s)
causes rapid B cell proliferation and IgM secretion (Jackson-
Jones and Be´ne´zech, 2018; Jackson-Jones et al., 2016). FALC
stromal cells produce IL-33 (Jackson-Jones et al., 2016), which
induces IL-5 secretion by ILC2s (Moro et al., 2010). Peritonitis in-
duces de novo FALC formation that is dependent on the produc-
tion of tumor necrosis factor (TNF) by monocytes and/or macro-
phages, and TNF receptor (TNFR) signaling in stromal cells
(Be´ne´zech et al., 2015). The initial recruitment of inflammatory
monocytes into FALCs requires MYD88 dependent activation
of Ccl19-expressing FALC stromal cells (Perez-Shibayama
et al., 2018). The cross-talk between monocytes and FALC stro-
mal cells supports B cell differentiation (Perez-Shibayama et al.,
2018) and FALC expansion (Be´ne´zech et al., 2015).
FALCs are highly vascularized (Cruz-Migoni and Caaman˜o,
2016; Meza-Perez and Randall, 2017) and act as gateways to
the peritoneal cavity during peritonitis. During TNF-induced peri-
tonitis, neutrophils rapidly transit through the high endothelial ve-
nules (HEVs) of omFALCs to enter the peritoneal cavity (Buscher
et al., 2016). The extravasation of cells into the peritoneal cavity
via FALCs may be facilitated by the presence of a loose lining of
mesothelial cells (Doherty et al., 1995; Hodel, 1970).
The ability of the omentum to collect peritoneal contaminants
is attributed to the flow of fluid from the peritoneal cavity through
the omentum, with omFALCs acting as an integrated filtrationlished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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system. Here, we investigated the mechanisms enabling the
capture of peritoneal contaminants by FALCs by first defining
the contribution of stromal-immune cell interactions to the cap-
ture and neutralization of contaminants. Single-cell RNA
sequencing (scRNA-seq) revealed heterogeneity within the sto-
mal compartment and defined two populations of mesothelial-
derived stromal cells. Three-dimensional reconstruction of
FALC stromal architecture showed that mesothelial-derived
stromal cells covered the surface of omFALCs. These cells pro-
duced immune mediators including the neutrophil recruitment
chemokine, CXCL1. CXCL1 was critical for the retention and
accumulation of neutrophils in omFALCs during Zymosan-
induced peritonitis. Neutrophil aggregates at omFALCs were
coated with neutrophil extracellular trap (NET)-like DNA struc-
tures that concentrated Zymosan particles. In vivo chemical inhi-
bition of protein arginine deiminase 4 (PAD4), an enzyme impor-
tant for NET formation, abolished neutrophil aggregation at
omFALCs and resulted in increased dissemination of peritoneal
contaminants to the spleen. Similar NET-like DNA structures
were detected within the omentum of patients with acute appen-
dicitis. Thus, stromal cells within omFALCs coordinate the
neutrophil response to restrict peritoneal contaminants. Manipu-
lating this pathway may provide therapeutic avenues for the
treatment of peritonitis.
RESULTS
scRNA-Seq Reveals the Presence of Three Distinct
Omental FALC Mesothelial Cell Populations
To characterize the mesothelial and stromal cell populations of
the omentum, we performed droplet-based scRNA-seq on iso-
lated mouse omental CD45CD41Ter119CD31PDPN+/
stromal cells from naive mice (Figure 1A). Unsupervised clus-
tering identified five populations visualized using UMAP (uniform
manifold approximation and projection) and a hierarchical clus-
ter tree (Figures 1B and 1C). Cluster 1 was designated as meso-
thelial cells because differentially expressed genes (DEGs;
genes with a 0.25 log-fold change and expressed in at least
25% of the cells in the cluster under comparison; Table S3)
were enriched for epithelial (Upk1b, Upk3b, Krt19, and Krt7)
andmesothelial (Msln andCd200) lineagemarker genes (Figures
1D–1F and S1A). Clusters 2 and 3 (Figures 1B and 1C) shared
similarity with mesothelial cells in keeping with the expression
of some epithelial lineage marker genes such as Upk1b,
Upk3b, Krt19, and Krt76 (Figures 1F and S1A). Cluster 2 was
distinguished by DEGs involved in the recruitment, adhesion,
or activation of immune cells such as Hdc, Enpp2, Ccl2, Cd44,
Il34,Cxcl10,Cxcl13,Cd55,Ctsc,Ccl7, andCxcl1 andwas desig-Figure 1. Identification of Non-endothelial Stromal Cell Populations w
(A) CD45CD41Ter119CD31PDPN+/ non-endothelial omental stromal cells
(B andC) Unsupervised clustering of non-endothelial omental stromal cells visualiz
and hierarchical cluster tree (C).
(D) Heatmap of each cell’s (column) scaled expression of DEGs (row) expressed
(E) Gene expression distinguishing the five clusters projected onto UMAP plots. C
(F–J) Violin plots of canonical omental stromal cell gene expression by cluster with
Cxcl13+ mesothelial cells (G), Ifit+ mesothelial cells (H), and Ccl11+ Pdgfra+ and M
(K) Representative gating strategy of non-endothelial omental PDPN+PDFGRa+CD
(red) stromal cells and level of expression of CD44 and CD55 in these population
702 Immunity 52, 700–715, April 14, 2020nated Cxcl13+ mesothelium (Figures 1D, 1E, 1G, and S1B). A
population of CXCL13+ stromal cells is found around the outside
of FALCs (Be´ne´zech et al., 2015; Rangel-Moreno et al., 2009).
The fact that Cxcl13+ mesothelial cells expressed mesothelial
markers suggested that Cxcl13+ cells were covering the surface
of FALCs. Cluster 3 was distinguished by DEGs associated with
interferon signaling such as Ifit3b, Ifit3, Ifit1, and Isg15, and anti-
viral responses such as Rsad2, and was designated as Ifit+
mesothelium (Figures 1D, 1E, 1H, and S1C). Pathway analysis
confirmed association of this cluster with interferon signaling
and anti-viral mechanism terms (Table S1). Pseudotime analysis
of the mesothelial cell cluster (cluster 1) to the Cxcl13+mesothe-
lial cluster (cluster 2) showed the gradual up and downregulation
of groups of genes along the mesothelial to Cxcl13+ mesothelial
trajectory (Figures S2A and S2C). Pseudotime analysis also re-
vealed groups of genes whose expression were gradually up
and downregulated along the mesothelial (cluster 1) to Ifit+
mesothelial (cluster 3) trajectory (Figures S2B and S2D). This
suggests that cells from the Cxcl13+ and Ifit+ mesothelial cell
clusters derive from mesothelial cells and acquire specific im-
mune functions.
scRNA-Seq Reveals the Presence of Two Distinct FALC
Fibroblast Populations within Omental Stroma
Clusters 4 and 5 displayed DEGs enriched for genes associated
with fibroblasts such as Fn1, Col4a1, Col14a1, and Pdgfra (Fig-
ures 1D, 1I, and S1D). Cluster 4 was distinguished by the expres-
sion of Ccl11 (also called Eotaxin) and assigned the name
Ccl11+Pdgfra+ fibroblasts (Figures 1B, 1E, and 1I). Cluster 5
was characterized by the expression of Matn2. FALC B cells of
the omentum and mesenteries are embedded in a dense
network of PDFGRa+ fibroblast reticular cells (FRCs) expressing
Ccl19 (Perez-Shibayama et al., 2018).Matn2+Pdgfra+ fibroblasts
expressed Ccl19 and showed enrichment for genes involved in
formation of the extracellular matrix (ECM) characteristic of
lymph node (LN) and FALC FRCs such as Sparcl, Spon2,
Col15a1, Bgn, Emilin1, and Spon1 (Figures 1D, 1I, and S1E)
(Huang et al., 2018; Malhotra et al., 2012; Perez-Shibayama
et al., 2018). They represented a distinct subset of FRCs, whose
gene expression profile did not fit into any of the LN stromal cell
populations recently described by scRNA-seq (Rodda et al.,
2018). In particular, Matn2+Pdgfra+ fibroblasts did not express
Il7,Ccl21,Bst1, orCxcl9, but expressed high levels ofCd34 (Fig-
ure 1J), Inmt, and Nr4a1 (Figure S1E). The Matn2+Pdgfra+ fibro-
blast subset was distinct from the populations of fibroblasts
identified in the inflamed synovium (Croft et al., 2019) and did
not express Fapa or Thy1. Ccl11+Pdgfra+ fibroblasts did not ex-
press Fapa and showed only limited expression of Thy1ithin the Omentum
were cell-sorted and underwent scRNA-seq.
edwith UMAP,where each dot is a single cell colored by cluster assignment (B)
by a minimum of 30% of cells per cluster.
olor scaled for each gene with highest log-normalized expression level noted.
highest log-normalized expression value labeled for the mesothelium (F and J),
atn2+ Pdgfra+ fibroblasts (I).
200 (blue), PDPN+PDFGRaintCD200int (green), and PDPN+PDFGRaCD200+
s. Fluorescence minus one control (FMO) in gray.
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(Figure S1D), thus suggesting that the adipose tissue is associ-
ated with distinct and specific fibroblast subsets.
All five clusters expressed Pdpn,Wt1,Cd34, Itgb1 (Cd29), and
Ly6a (Sca-1), which have been used collectively to identify cells
of mesothelial origin giving rise to adipocytes in visceral fat de-
pots (Figures 1J and S1F; Chau et al., 2014). Regulation of retinol
metabolism by Wt1-expressing cells is critical to maintain
GATA6+ resident macrophages in the peritoneal cavity (Buechler
et al., 2019). The two step-limiting enzymes of retinol metabolism
were expressed by omental stromal cells with expression of
Aldh1a1 by mesothelial cells and Aldh1a2 by both mesothelial
cells and Ccl11+Pdgfra+ fibroblasts (Figure S1F). Il33 was ex-
pressed by all three mesothelial clusters (Figure 1J), in agree-
ment with previous reports (Mahlako˜iv et al., 2019; Spallanzani
et al., 2019) as well as in FALC FRCs, confirming our previous
observation that IL-33 is expressed by FALC stromal cells (Jack-
son-Jones et al., 2016).
Cxcl13+ and Ifit+ Mesothelial Cells Are Present in Other
Adipose Tissues Rich in FALCs
Distinct clusters of PDPN+PDGFRa+ fibroblasts and PDPN+-
PDGFRa mesothelial cells are found in the mesenteric adipose
tissue (Koga et al., 2018). As mesenteries contain FALCs, we
reasoned that cells corresponding to Cxcl13+ and Ifit+ mesothe-
lial cells should be identifiable within the mesenteric scRNA-seq
dataset (Koga et al., 2018). Projection of the mesenteric PDPN+
PDGFRa mesothelial cell dataset onto our omental stromal da-
taset confirmed the presence of Cxcl13+ and Ifit+ mesothelial
cells in the mesenteries (Figures S2E–S2G). Projection of the
mesenteric PDPN+PDGFRa+ fibroblasts onto our omental stro-
mal dataset confirmed the presence of Matn2+ fibroblast cells
in the mesenteries (Figures S2E, S2F, and S2H).
We compared the gene expression profile of PDPN+PDGFRa
mesothelium from the gonadal adipose tissue, which does not
contain FALCs, with the PDPN+PDGFRa mesothelium of the
omentum using published RNA-seq datasets (Buechler et al.,
2019). A number of genes were overexpressed in the omental
mesothelium, including DEGs characterizing the Cxcl13+ meso-
thelial cluster such as Krt76,Cd55,Cd44,Ccl2,Hdc, Enpp2, and
Cxcl1 (Figure S1H; Table S4). In our omental dataset, Cxcl13+
mesothelial cells were distinguished from mesothelial cells by
195 DEGs (Table S5). Of these, 68 were also overexpressed in
the omental mesothelium compared to the gonadal fat pad
mesothelium of the Buechler et al. dataset (Figure S1G), confirm-Figure 2. FALCs Are Covered by a Differentiated Monolayer of Mesoth
(A) 3D reconstruction of a large portion of the omentum obtained by imaging of w
(B and C) Confocal imaging and 3D reconstruction of an omFALC showing a view
(B) and of the surface of the omentum (C) with PDPN (red), CXCL13 (green), DAP
(D–F) Representative confocal imaging and 3D reconstruction of an omFALC show
with PDPN (red); ENPP2 (D, green), Cathepsin-C (E, CTSC, green), or ISG15 (F, gr
the cluster and the mesothelium are delimited by a hyphenated line.
(G) Violin plots of gene expression of inflammatory chemokines by cluster with h
(H) Amounts of CCL2, CXCL10, and CXCL1 secreted into the supernatant of 2-h o
for 2 h either in vivo (i.p. injection) or ex vivo. Data pooled from two independent
(I) Confocal imaging and 3D reconstruction of omFALC showing the surface of o
Scale bars, 100 mm.
All staining representative of n R 8 clusters from nR 4 mice in at least two ind
multiple comparisons test or ANOVA with Sidak’s multiple comparisons test was
ns = non-significant, ***p = < 0.001.
704 Immunity 52, 700–715, April 14, 2020ing that the Cxcl13+ mesothelial cluster was associated with the
presence of FALCs in the adipose tissue.
Flow-cytometric analysis of FALC-rich tissues confirmed the
presence of PDGFRaPDPN+CD200+CD55/lowCD44low meso-
thelial cells and PDGFRa+PDPN+CD200CD55intCD44 fibro-
blasts in the omentum and allowed the identification of a popu-
lation of cells transitioning from PDGFRaCD200high to
PDGFRa+CD200 expressing high levels of CD55 and CD44 in
keeping with the gene expression profile of Cxcl13+ mesothelial
cells (Figure 1K). Detection of CD200 on the surface of Cxcl13+
mesothelium suggested maintenance of protein expression
followingCd200 transcript downregulation (Figure 1F) during dif-
ferentiation frommesothelial cells. In mouse, the omentum is the
tissue with the highest abundance of FALCs, followed by peri-
cardium, mediastinum, and mesenteries (Be´ne´zech et al.,
2015). In keeping with the relative abundance of FALCs in these
tissues, the omentum was the tissue with the highest proportion
of Cxcl13+ mesothelial cells identified as PDPN+PDGFRaint
CD200int cells, followed by the pericardium, mediastinum, and
mesenteries. The gonadal adipose tissue, which does not
contain FALCs, showed minimal PDPN+PDGFRaintCD200int
cells (Figure S3A).
FALCs Are Covered by a Monolayer of Stromal Cells
Expressing Markers of Cxcl13+ and Ifit+
Mesothelial Cells
To elucidate the spatial organization of FALCs, we performed
wholemount immunofluorescence staining using marker genes
identified from our scRNA-seq analysis. The B cell positioning
chemokine CXCL13 was found within PDPN+ mesothelial cells
covering the surface of omFALCs (Figures 2A and 2B; FALC),
as well as pericardial FALCs (Figure S3B). The morphology of
these cells differed from the typical cobblestone appearance of
PDPN+ mesothelial cells, which surrounded the FALC and did
not express CXCL13 (Figures 2A and 2C; mesothelium). The ly-
sophospholipase ENPP2 (Ectonucleotide Pyrophosphatase/
Phosphodiesterase 2), expression of which was enriched in the
Cxcl13+ FALC stromal cell population, was also present at high
levels on the surface of FALCs and was expressed by
CXCL13+ cells (Figures 2D, S4A, and S4B). The lysosomal
cysteine protease Cathepsin-C (Ctsc; also known as di-peptidyl
peptidase I) was present within PDPN+ stromal cells covering
omFALCs, but not within the mesothelial surface outwith the
FALC (Figures 2E and S4C). Our results thus confirm theelial Cells
holemount staining of the omentum showing omFALCs with DAPI (white).
of the surface of the cluster and a z section (along the dotted line) of the cluster
I (blue), and IgM (yellow).
ing a view of the surface of the cluster and a z section (dotted line) of the cluster
een); DAPI (blue) and IgM (D, yellow); or CD45 (E and F, yellow). The surface of
ighest log-normalized expression value labeled.
mentum explant culture per omentum and per ml after exposure to Zymosan-A
experiments with n = 10 mice per group.
mFALCs (first column) and a clipped view inside the cluster (second column).
ependent experiments. Error bars show SEM. Kruskal Wallis test with Dunn’s
applied after assessing normality using D’Agostino and Pearson normality test,
A B E
C D
F
Figure 3. CXCL1 Is Required for the Recruitment of Neutrophils into omFALCs
(A) Number of neutrophils in digested omentum as assessed by flow-cytometric analysis (Figure S5A) of naive (white bar) and at the indicated time points following
i.p. injection of Zymosan-A (blue bars). Data pooled from two independent experiments with n = 5–11 mice per group.
(B) Representative confocal imaging and 3D reconstruction of omFALCs from naive and 6 h post-Zymosan mice, DAPI (magenta) and Ly6G (white). Scale
bar, 200 mm.
(C) Quantification of themean gray value of Ly6G andMPO stained as in Figure S5B of omenta from naive (white bar) and at the indicated time points following i.p.
injection of Zymosan (blue bars). Data for cluster quantification pooled from two independent experiments with nR 24 imaged clusters from n = 8mice per group.
(D) Quantification of the volume of omFALCs at the indicated times following i.p. injection of Zymosan-A (blue). Data pooled from two independent experiments
with nR 32 imaged clusters from n = 6 mice per group.
(legend continued on next page)
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existence of a mesothelial-derived population of cells covering
the surface of FALCs and expressing ENPP2, CXCL13, and
Cathepsin-C, which we named Cxcl13+ FALC cover cells.
ISG15 was found in the cytoplasm of a subset of the PDPN+ cells
covering omFALCs, confirming the existence of Ifit+ mesothelial
cells. ENPP2 and ISG15 were co-expressed by PDPN+ cover
cells (Figures 2F and S4D). We named these cells Ifit+ FALC
cover cells. PDPN+ FALC FRCs, which formed a reticular
network at the core of the cluster, expressed very low levels of
ENPP2 as predicted (Figure S4A, enlargement 4). Finally, stain-
ing for CCL11 revealed that fibroblasts contained in the adipose
(non-FALC) stroma of the omentum expressed high levels of
CCL11, while FALC FRCs and mesothelial cells did not (Figures
S4E and S4F).
Cxcl13+ FALC Cover Cells Express Inflammatory
Chemokines
The Cxcl13+ FALC cover cell cluster was distinguished by the
expression of the monocyte chemoattractants Ccl2 and Ccl7
and the neutrophil chemoattractants Cxcl1 and Cxcl10 (Fig-
ure 2G), suggesting a role for these cells in orchestrating the
recruitment of inflammatory cells during peritonitis. The expres-
sion ofCxcl1was also enriched inCcl11+Pdgfra+ fibroblasts and
Matn2+Pdgfra+ fibroblasts. Analysis of omental explant culture
supernatants showed that CXCL1 protein was released at
steady state by the omentum and that CXCL1 secretion was
potentiated after a 2 h exposure to Zymosan-A, in vivo or ex
vivo (Figure 2H). In contrast, the two other early chemo-attrac-
tants, CCL2 and CXCL10, were released by the omentum only
after peritoneal inflammation was triggered by Zymosan-A, and
this could not be recapitulated ex vivo (Figure 2H). This suggests
that CXCL1 is constitutively produced by the omentum, while the
initial secretion of CCL2 and CXCL10 is dependent on the early
recruitment of immune cells upon sensing of an inflammatory
signal. In addition, the rapid induction of secretion of CXCL1 (2
h) suggests that this is due to release of pre-formed CXCL1
rather than an increase in transcription. Radiation-resistant stro-
mal-derived CXCL1 is important in the control of bacterial infec-
tion during peritonitis (Jin et al., 2017). Protein expression of
CXCL1 was particularly high in FALC cover cells within the
omentum (Figure 2I), as well as the pericardium andmesenteries
(Figures S3C and S3D). While the expression of Cxcl1 was
comparable in the Cxcl13+ mesothelial cell cluster and the
Matn2+Pdgfra+ and Ccl11+Pdgfra+ fibroblast clusters, CXCL1
protein was much higher in FALC cover cells, suggesting that
these cells retain intracellular stores of CXCL1. Given the
spatially constrained expression of CXCL1 over the surface of
FALCs and that neutrophils use FALC HEVs to enter the perito-
neal cavity (Buscher et al., 2016), we next assessed whether(E) Representative confocal images of omentum, the peritoneal surface of the
(magenta) and Ly6G (white) and quantification of the mean gray value of Ly6G fo
mice (blue). Data for cluster quantification pooled from two independent experim
(F) Representative density plots showing proportion of neutrophils found in the pe
combination with the injection of anti-CXCL1 or isotype control antibodies after 2
treated mice. Data pooled from two independent experiments with n = 5–11 mic
Error bars show SEM. Box and whiskers showing min to max value. Kruskal Wal
comparisons test was applied after assessing normality using D’Agostino and Pe
0.001, ****p = < 0.0001.
706 Immunity 52, 700–715, April 14, 2020CXCL1 was important for the recruitment of neutrophils to
omFALCs during peritonitis.
CXCL1Mediates Active Recruitment of Neutrophils into
omFALCs
To characterize the dynamics of neutrophil recruitment to om-
FALCs during peritonitis, we used the well-established murine
model, Zymosan-A-induced peritonitis. Peritonitis led to a tran-
sient increase in the number of Ly6G+ neutrophils in the
omentum, peaking at 24 h (Figures 3A and S5A). Wholemount
immunofluorescence staining and confocal analysis revealed
that FALCs were the site of extensive recruitment of Ly6G+
Myeloperoxidase+ (MPO) neutrophils, which formed dense
cellular aggregates between 6 and 24 h post-induction of peri-
tonitis (Figures 3B, 3C, and S5B). The volume of omFALCs
increased exponentially during the first 18 h post-Zymosan in-
jection (75-fold) before rapidly contracting back to their normal
size by 24 h (Figure 3D). This timing coincided with the influx of
MPO+ neutrophils and their disappearance by 24 h (Figures 3C
and 3D). This accretion of neutrophils was specific to omFALCs
and did not happen on the rest of the surface of the omentum,
the diaphragm, or the parietal wall (Figures 3E, S5C, and S5D).
We then tested whether CXCL1 was involved in the accumula-
tion of neutrophils at omFALCs during peritonitis, using an
anti-CXCL1 blocking antibody. Eighteen hours post-Zymosan
injection, CXCL1 blockade led to a 2.6-fold decrease in the
number of neutrophils recovered from the omentum compared
to mice treated with isotype control antibodies. There was
no difference in the number of neutrophils recovered from the
peritoneal cavity, suggesting that the trafficking of neutrophils
through omFALC HEVs was not altered (Figure 3F). Thus,
the extensive recruitment of neutrophils to FALCs is not
simply a consequence of increased trafficking of neutrophils
through HEVs, but the result of active retention dependent
upon CXCL1.
To confirm that the omentum is a major source of CXCL1 dur-
ing peritonitis, we quantified secretion of CXCL1 following 2 h
ex vivo explant culture of omentum, mesenteries, peritoneal
wall, diaphragm, and liver from naive mice and at 2 h following
injection of Zymosan-A. In contrast to liver, the mesenteries,
peritoneal wall, and diaphragm all significantly increased secre-
tion of CXCL1 following exposure to Zymosan-A in vivo; how-
ever, per mg of tissue, the omentum secreted significantly
more CXCL1 than any of these peritoneal tissues (Figure S5E).
Having established that FALC cover cells constituted an impor-
tant store of CXCL1, and that inflammation led to rapid release of
pre-formed CXCL1, we next assessed the effect of inflammation
on the expression of Cxcl1 mRNA in various omental cell
fractions: PDPN+CD31PDGFRa+CD200 fibroblasts, PDPN+diaphragm, and parietal wall from naive and 6 h post-Zymosan mice, DAPI
r omFALCs, parietal wall, diaphragm from naive (white) and 6 h post-Zymosan
ents with nR 24 imaged clusters from n = 6 mice per group. Scale bar, 50 mm.
ritoneal exudate cells (PECs) and omentum 18 h post Zymosan i.p injection, in
h and number of neutrophils found in PECs and per g of omentum in naive and
e per group.
lis test with Dunn’s multiple comparisons test or ANOVA with Sidak’s multiple
arson normality tests, ns = non-significant, * = p < 0.05, ** = p < 0.01, ***p = <
AB
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Figure 4. CitH3+DNACoatsNeutrophil Aggregates
on omFALCs during Peritonitis
(A) Representative confocal images of wholemount stain-
ing of omentum from naive and 6 h post-Zymosan mice
DAPI (magenta), CitH3 (green), and Ly6G (blue). Scale bar,
50 mm.
(B) Quantification of the number of CitH3 positive nuclei
per mm at the times indicated post-Zymosan injection.
Data for cluster quantification pooled from two indepen-
dent experiments with nR 24 imaged clusters from n = 8
mice per group. Box and whiskers showing min to max
value.
(C) 3D reconstruction of omFALC at 6 h post-Zymosan
injection showing the surface of a cluster (first row) and a
clipped view inside the cluster (second row). Ly6G (blue),
CitH3 (green), DAPI (magenta). Scale bar, 100 mm.
(D) WT or Elane/ mice were left naive (WT white,
Elane/ gray) or injected i.p. with Zymosan (WT blue,
Elane/ gray). Omenta were collected 18 h post-injection.
The number of CitH3+ cells per mm and volume of each
cluster were assessed by wholemount staining and
confocal analysis of omenta from naive and treated mice.
Data for cluster quantification pooled from two indepen-
dent experiments with n R 14 (CitH3+ cells) or n R 20
(cluster size) imaged clusters from n = 4 mice per group.
(E) Representative confocal images of omFALCs at 6 h
following Zymosan injection showing MPO (green), Ly6G
(blue), CitH3 (white), and DAPI (magenta). Staining repre-
sentative of n R 24 clusters from n R 8 mice in two in-
dependent experiments. Scale Bar, 50 mm.
Student’s t test, Kruskal Wallis test with Dunn’s multiple
comparisons test, or Mann Whitney test was applied after
assessing normality using D’Agostino and Pearson
normality test, ns = non-significant, ****p = < 0.0001.CD31PDGFRaintCD200int FALC cover cells, PDPN+CD31
PDGFRaCD200+ mesothelial cells, PDPNCD45CD31+
endothelial cells, and CD45+ hematopoietic cells. Two hour
Zymosan-A exposure significantly increased the transcription
of Cxcl1 by all populations assessed, except the hematopoietic
population, where Cxcl1 expression remained low, confirmingthe stromal origin of CXCL1within the omentum.
The highest expression of Cxcl1 was found in fi-
broblasts and FALC cover cells (Figure S5F).
Neutrophils Form Large Aggregates in
omFALCs, Which Are Encapsulated in
NET-like Structures
Immunofluorescence imaging analysis of accu-
mulated neutrophils within omFALCs revealed
the presence of multiple areas of DAPI staining
presenting with a non-nuclear appearance (Fig-
ure 4A, right). Neutrophils have the capacity to
form NETs, which consist of uncoiled DNA
scaffold decorated with proteases and anti-mi-
crobial peptides found in neutrophil granules.
NETs are formed as a defense mechanism to
immobilize invading microorganisms but also
in response to sterile triggers (Boeltz et al.,
2019; Papayannopoulos, 2018). In some condi-
tions, NETs mediate neutrophil aggregation(Leppkes et al., 2016; Mun˜oz et al., 2019; Schauer et al., 2014).
Chromatin decondensation, which is required for the formation
of NETs, can be mediated by the citrullination of histones. Stain-
ing for citrullinated histone H3 (CitH3) revealed that the areas of
DAPI staining presenting with an extruded DNA pattern were
highly stained for CitH3 (Figure 4A). CitH3+ DNA was found inImmunity 52, 700–715, April 14, 2020 707
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FALCs between 6 and 18 h post-Zymosan injection at the peak of
neutrophil recruitment (Figures 4B, 3A, and 3C). The highest den-
sity of CitH3+ DNA was found on the surface of the expanded
FALCs, which typically formed a dense core of neutrophils
coatedwith aCitH3+DNAouter-layer (Figures4C,S6A, andS6B).
To further characterize the CitH3+ DNA outer-layer and deter-
mine if it could be considered as NETs, we analyzed the require-
ment for Neutrophil elastase (NE). NE is a granule serine protease
which translocates to the nucleus, where it promotes chromatin
decondensation and the formation of NETs (Papayannopoulos
et al., 2010). Here, we found that the formation of the CitH3+
DNA layer coating omFALC neutrophil aggregates, and the
expansion of these structures during Zymosan-induced perito-
nitis was not affected in NE-deficient Elane/ mice compared
to wild-type (WT) mice (Figure 4D). MPO, another granule serine
protease, synergizes the action of NE and is found associated
with NETs (Papayannopoulos et al., 2010). Staining for MPO re-
vealed that the CitH3+ DNA covering the neutrophil aggregates
was not associated with MPO, suggesting that MPO relocation
to the nucleus is not required for the formation of the CitH3+
DNAouter-layer (Figure 4E). Given that the neutrophil aggregates
formed independently ofNE,wesought to confirm that the aggre-
gates were formed by neutrophils. Injection of anti-Gr1 anti-
bodies successfully mediated depletion of the Ly6G+ peritoneal
neutrophil population at 6 h following Zymosan-A intraperitoneal
(i.p.) injection (Figure S7A). Following depletion of peritoneal neu-
trophils, no accretion of Ly6G+ neutrophils, staining for CitH3+,
nor expansion in cluster volume occurred within the omentum
(Figure S7B). Therefore, the formation of the CitH3+ DNA layer
coating the omFALC aggregates that appear during Zymosan-
induced peritonitis is formed by neutrophils independently of
NE and thus different from the formation of ‘‘classical’’ NETs.
Inhibition of PAD4 Prevents the Aggregation of
Neutrophils in omFALCs and the Trapping of Zymosan
by omFALCs
The enzyme PAD4, which mediates the conversion of arginine
into citrulline, is implicated in vitro and in vivo in the formation
of NETs. The role of PAD4 in NET formation remains controver-
sial and seems to be context dependent (Boeltz et al., 2019; Ko-
nig and Andrade, 2016). In order to test whether PAD4 was
involved in the capture of particulate contaminants and the for-
mation of neutrophil aggregates on omFALCs, we used fluores-
cently labeled Zymosan (Fluo-Zym) and the specific PAD4 inhib-
itor GSK484 (Lewis et al., 2015). Observation of the omentumFigure 5. Inhibition of PAD4 Prevents Neutrophil Aggregation and Ca
Retention of Zymosan in the Peritoneal Cavity and Spread to the Splee
Micewere left naive (white) or injected i.p. with Fluo-Zym in combination with the P
were analyzed 6 h post injection.
(A and B) Representative low (A, scale bar 1 mm) and high (B, scale bar 50 mm) m
omentum.
(C–E) Number of Fluo-Zym particles per mm2 of omFALCs (C), mean gray value
(F) Total number of PEC neutrophils.
(G) Representative histogram showing fluorescence intensity of Fluo-Zym in all P
(H) Number of Fluo-Zym+ neutrophils and MFI of Fluo-Zym within Fluo-Zym+ neu
(I) Representative histogram showing fluorescence intensity of Fluo-Zym in splee
Data for cluster quantification pooled from two independent experiments with nR
pooled from two independent experiments with n = 7–8 mice per group. Kruska
applied after assessing normality using D’Agostino and Pearson normality test, nwith a stereo-microscope at 6 h post-injection revealed that om-
FALCs had undergone a massive expansion and very effectively
captured and concentrated Fluo-Zym particles in FALCs (Fig-
ure 5A). In contrast to the omentum, the epidydimal fat pad,
parietal wall, and diaphragm did not capture any Fluo-Zym (Fig-
ure S7C). The Fluo-Zym particles were concentrated in
dispersed spots on the mesenteries in keeping with the lower
proportion of FALCs within this tissue compared to the omen-
tum. PAD4 inhibition completely abrogated both the omFALC
expansion and the capture of Fluo-Zym particles by omFALCs
(Figures 5A–5C). Fluo-Zym injection led to the formation of large
neutrophil aggregates embedded in CitH3+ DNA, while PAD4 in-
hibition blocked the recruitment of Ly6G+ neutrophils into om-
FALCs and significantly reduced the CitH3 staining compared
to Fluo-Zym-only controls (Figures 5B and 5D). PAD4 inhibition
was associated with omFALCs failing to capture Fluo-Zym par-
ticles and expand in size (Figures 5A and 5E).
In contrast, GSK484 did not block the recruitment of neutro-
phils into the peritoneal cavity since we recovered twice as
many neutrophils from the peritoneal cavity when mice received
GSK484 and Fluo-Zym compared to Fluo-Zym only (Figure 5F).
Thus, GSK484 inhibits neutrophil accretion in omFALCs, leading
to a very severe reduction in the capacity of the omentum to cap-
ture Zymosan particles. While neutrophils clearly underwent cit-
rullination of Histone H3 during Zymosan-induced peritonitis, the
fact that PAD4 inhibition led to a near-complete abrogation of
neutrophil aggregation within FALCs did not allow us to conclude
whether PAD4 was involved in the formation of the CitH3+ DNA
outer-layer we observed.
Inhibition of PAD4 Leads to Impaired Clearance of
Zymosan Particles from the Peritoneal Cavity and
Increases Dissemination to the Spleen
We next addressed the effect of PAD4 inhibition on peritoneal
neutrophil clearance of Zymosan-A. Inhibition of PAD4 resulted
in a significant increase in the retention of neutrophils and
Fluo-Zym particles within the peritoneal cavity (Figures 5F and
5G). There was a 3-fold increase in the proportion of neutrophils
retaining Fluo-Zym particles, with a near 2-fold increase in Fluo-
Zym mean fluorescence intensity (MFI), indicating that PAD4 in-
hibition led to increased phagocytosis of Fluo-Zym particles by
peritoneal neutrophils (Figure 5H). Finally, PAD4 inhibition led
to increased dissemination of Fluo-Zym particles to the spleen
(Figure 5I). Thus, this suggests that PAD4-dependent neutrophil
aggregation within omFALCs provides a rapid and efficientpture of Zymosan Particles within omFALCs While Increasing the
n
AD4 inhibitor GSK484 (red) or vehicle (blue) and the omentum. PECs and spleen
agnification confocal images of wholemount immunofluorescence staining of
for CitH3 and Ly6G staining (D), volume of omFALCs (E).
ECs and number of Fluo-Zym+ PECs.
trophils.
n and percentage and number of Fluo-Zym+ events per spleen.
30 (C–D) and nR 60 (E) imaged clusters from n = 7–8 mice per group. Data
l Wallis test with Dunn’s multiple comparisons test or Mann Whitney test was
s = non-significant, ** = p < 0.01, ***p = < 0.001, ****p = < 0.0001.
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Figure 6. CXCL1 and PAD4 Are Required for the Adhesion of Bacteria to the Omentum in the Absence of Fluid Flow
(A) Representative confocal images of wholemount staining of omenta, isolated from either naive animals or 18 h after Zymosan i.p injection, in combination with
the injection of either anti-CXCL1 or isotype control antibodies, and cultured with fluorescently labeled E. coli bio-particles for 10 min. Number of E. coli bio-
particles found per cluster section and per mm2 of cluster were graphed. MPO (white), E. coli (green), DAPI (red), Ly6G (blue). Data for cluster quantification pooled
from two independent experiments with nR 18 imaged clusters from n = 10–11 mice per group. Error bars show SEM.
(B) Mice were left naive (white circles) or injected i.p. with Zymosan in combination with the PAD4 inhibitor GSK484 (gray circles) or vehicle (blue circles). The
omenta were collected 18 h post-injection and incubated in vitro for 5 min with mCherry+ E. coli. Representative confocal images of wholemount staining of
omentum. E. coli (green), DAPI (magenta). Mean gray value of E. coli in omFALCs and percentage area covered by E. coli.
Data for cluster quantification pooled from two independent experiments with n R 10 imaged clusters from n = 7–8 mice per group. Error bars show SEM.
Kruskal Wallis test with Dunn’s multiple comparisons test were applied after assessing normality using D’Agostino and Pearson normality tests, ns = non-sig-
nificant, ** = p < 0.01, ***p = < 0.001, ****p = < 0.0001. Scale bars, 50 mm.mechanism to clear particulate material from the peritoneal cav-
ity and limit the systemic spread of peritoneal contaminants.
Neutrophil Recruitment and Aggregation Confer
Increased Adhesive Properties to omFALCs
In the peritoneal cavity, the capture of particles by omFALCs
results from a combination of peritoneal fluid flow through710 Immunity 52, 700–715, April 14, 2020the omentum and the capacity of the omentum to retain these
particles. To assess the importance of neutrophil aggregation
on the adhesive properties of the omentum independent
of fluid flow, we measured ex vivo the capacity of the
omentum to capture bacteria relevant to peritonitis by briefly
incubating fluorescently labeled E. coli bioparticles with omen-
tum samples isolated from untreated control mice, or from
mice undergoing Zymosan-induced peritonitis that had been
treated with isotype control antibodies or anti-CXCL1 anti-
bodies in vivo (Figure 6A). Omenta were collected at 18 h
post-Zymosan injection and incubated ex vivo for 5 min at
room temperature with E. coli bioparticles before fixation and
wholemount immunofluorescence imaging. Omentum tissue
sampled from mice with peritonitis proficiently trapped
E. coli, whereas those from control mice without peritonitis
did not (Figure 6A). Blockade of CXCL1 resulted in fewer neu-
trophils within the omentum and a failure to efficiently trap
E. coli, indicating that CXCL1-mediated recruitment of neutro-
phils to the omentum dramatically increased the capacity of
the omentum to capture bacterial contaminants. We confirmed
the importance of neutrophil recruitment and aggregation for
the increased adhesive properties of the omentum during peri-
tonitis using omenta isolated from naive mice, those undergo-
ing peritonitis, those undergoing peritonitis with PAD4 inhibi-
tion, and E. coli expressing the fluorescent protein mCherry.
Omenta from naive mice did not trap E. coli, contrary to
omenta from mice with peritonitis (containing NET-like struc-
tures), where large areas of FALCs were covered in E. coli.
PAD4 inhibition led to a marked decrease in the efficiency
with which the omentum captured E. coli (Figure 6B). These
data suggest that neutrophil aggregation within omFALCs dur-
ing peritonitis contributes to omental clearance of peritoneal
bacterial contaminants.
Neutrophils Are Recruited to the Human Omentum
during Peritonitis
We reasoned that appendicitis would provide a useful transla-
tional platform to examine the function of the omentum during
peritonitis. During acute appendicitis, the omentum wraps itself
around and adheres to the inflamed appendix (Morison, 1906).
By comparison, in patients undergoing laparoscopic surgery
for biliary colic (surgery for gallstones without active inflamma-
tion), the omentum and appendix are both uninvolved. We re-
cruited patients who were undergoing laparoscopic surgery for
possible or suspected acute appendicitis or laparoscopic chole-
cystectomy for biliary colic (non-inflamed, NI; Table S2). Acute
appendicitis induced a stark influx of CD16+CD14CD19
CD3CD56CD15+ neutrophils into the omentumand the perito-
neal cavity (Figures 7A and 7B).
We next investigated whether the mechanisms regulating
recruitment of neutrophils to the human omentum were similar
to mouse by analyzing the secretion of inflammatory chemo-
kines and cytokines over a 2 h interval in ex vivo human omen-
tum explant cultures (Figure 7C). CXCL8 (human homolog of
murine CXCL1) and IL-1b, two important factors for neutrophil
recruitment and activation (Biondo et al., 2014), were secreted
at much higher levels in omental explant cultures and peritoneal
lavage in inflammatory conditions compared to controls, but
not in serum (Figures 7C and 7D). In patients with acute appen-
dicitis, 1 g of omental explant released 25 ng of CXCL8,
approximately 400 times more than the amount found per ml
of peritoneal lavage, despite the number of neutrophils being
similar in equivalent volumes of omentum and wash fluid
(Figures 7B and 7D), indicating that the human omentum is a
key site of CXCL8 release and neutrophil recruitment during
peritonitis.CitH3+ NET-like Structures Are Released on the Human
Omentum during Peritonitis
Finally, we tested whether neutrophils recruited to the omentum
during peritonitis in humans also released CitH3+ NET-like struc-
tures. Wholemount immunofluorescence staining showed the
presence of extracellular DNA fibrils stained with SYTOX or
DAPI, which co-localize with CitH3, in regions where there was
a substantial CD15+ neutrophil infiltrate during acute appendi-
citis (Figure 7E). Areas of CitH3+ DNA staining which did not
co-localize with MPO were found, comparable to the murine
omentum during peritonitis. No NET-like structures were de-
tected in any NI control samples (Figure 7E). Double-stranded
(ds)DNA was found in omental explant culture supernatants
and in the peritoneal wash fluid from patients with acute appen-
dicitis, but not from control patients (Figure 7F). Since an equiv-
alent number of neutrophils were present per g of omentum and
per ml of peritoneal wash (Figure 7B), the fact that dsDNA was
released in the greatest amounts by the omental explants
strongly suggests that the omentum supports DNA release
from neutrophils. Using a limulus amoebocyte lysate (LAL)
assay, we measured bacterial LPS within omental explant cul-
tures and detected LPS release into culture supernatants from
omentum isolated from patients with acute appendicitis, but
not from NI patients. Patients with appendicitis also had higher
serum levels of LPS, but there was no evidence of LPS within
the peritoneal wash (Figure 7G). This suggested that during
appendicitis, neutrophil aggregation and the release of CitH3+
NET-like structures on the omentummediate successful capture
of bacterial antigens arising from the inflamed appendix and thus
protect the wider peritoneal cavity from contamination and
generalized peritonitis.
DISCUSSION
In the present study, we uncovered important facets of stromal-
immune cell interactions, which governed omFALC function
within the peritoneal cavity and revealed how neutrophils medi-
ated the clearance of peritoneal contaminants by omFALCs.
The surface of FALCs was covered by differentiated mesothelial
cells specialized in the secretion of inflammatory mediators
(Cxcl13+ FALC cover cells) and the response to virus (Ifit+
FALC cover cells). During peritonitis, neutrophils rapidly accu-
mulated within omFALCs, where they formed large aggregates
concentrating peritoneal contaminants. The formation of these
aggregates was dependent on two mechanisms: (1) CXCL1,
which was produced by Cxcl13+ FALC cover cells; and (2) the
PAD4-dependent formation of a CitH3+ DNA outer-layer coating
the omFALC neutrophil aggregates. In humans with appendi-
citis, the omentum was also a site of neutrophil recruitment
and the release of CitH3+ DNA. In addition, we provided evi-
dence that the omentum efficiently captured bacterial antigens,
leaving the peritoneal cavity free of contamination.
In the omentum, themesothelium acts as a filtration system for
peritoneal fluid. Entrance of peritoneal fluid is facilitated by the
presence of stomata (Mironov et al., 1979) that afford particles
and cells entrance into FALCs and enable fluid to be drained
into neighboring lymphatic vessels. Our analysis revealed the
exquisite adaptation of the mesothelium for this function, which
gave rise to Cxcl13+ FALC cover cells, specialized in theImmunity 52, 700–715, April 14, 2020 711
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Figure 7. The Human Omentum Recruits Neu-
trophils and Collects Bacterial Antigens during
Appendicitis
(A,) Representative gating strategy showing CD45+
CD19, CD3, NCAM, and CD15+ neutrophils in the
omentum (Om) of non-inflamed (NI) and appendicitis
(App) patients. Histogram showing expression of
CD16 and CD14 by omental neutrophils from repre-
sentative patients with App, and quantification of
CD16 and CD14 MFI on CD15+ neutrophils from NI
(white) and appendicitis (red) patients.
(B) Number of neutrophils found per g of Om or per ml
of peritoneal wash (PW) of NI and App patients. Pa-
tients were stratified based on surgical outcome into
one of two groups, NI (white) or App (red), n = 7 and 10
patients per group. Error bars show SEM.
(C,) Chemokines and cytokines found in 2 h Om
explant culture supernatant, PW, and serum
comparing NI and App patients. Each column repre-
sents one patient.
(D) Amounts of CXCL8 per g per ml of 2 h Om explant
culture supernatant.
(E) Representative confocal images of wholemount
immunofluorescence staining of omentum biopsies
from NI or App patients (nR 6) showing in gray DNA
stained with DAPI (upper) or extracellular DNA stained
with SYTOX (middle, gray), or CD15 (lower); in
magenta CD11b; in green MPO and in red Citrulli-
nated histone H3 (CitH3).
(F) Amounts of double-stranded DNA (dsDNA)
released into the supernatant of 2 h omental explant
culture per g and per ml and per ml of PW in control
and App patients.
(G) LAL activity within the supernatant of 2 h omental
explant culture per g and per ml of PW and serum in
control and appendicitis patients. n = 10–13 patients
per group.
Error bars show SEM. Unpaired Student’s t test or
Mann Whitney test was applied after assessing
normality using D’Agostino and Pearson and Shapiro-
Wilk normality tests, ns = non-significant, * = p < 0.05,
** = p < 0.01, ***p = < 0.001.
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attraction of immune cells and the secretion of inflammatory me-
diators and Ifit+ FALC cover cells competent for the secretion of
anti-viral factors. Cxcl1 was expressed by both Cxcl13+ FALC
stromal cells and Pdgfra+ fibroblast, but only FALC cover cells
had intra-cellular stores of CXCL1, suggesting that CXCL1 pro-
duction was post-transcriptionally regulated in FALC cover cells.
In absence of a genetic model allowing the specific deletion of
Cxcl1 in FALC cover cells, we cannot rule out that CXCL1 from
other cellular sources is important for the recruitment of neutro-
phils to the omentum. Based on our results, we hypothesize that
following the initial Cxcl13+ FALC cover cell CXCL1 mediated
recruitment of zymosan-loaded peritoneal neutrophils to om-
FALCs; the release of extracellular DNA facilitates the adhesion
of further waves of neutrophils, which also extrude their DNA, re-
sulting in the large aggregates imaged at 6–18 h. To account for
the staining pattern seen, we assume that re-modeling of the
DNA extrusions must occur to clear CitH3 from the center of
the aggregates while leaving the fluid-facing aggregates coated
in NET-like structures. This intriguing CitH3+ DNA outer-coating
raises multiple questions., (1) what is the role of the CitH3+ DNA
on the fluid facing surface of the cluster; are CitH3+ neutrophil-
aggregated omFALCs anti-bacterial? (2) Are the aggregations
performing a purely structural role by barricading the omFALC
to limit the spread of peritoneal contaminants? (3) How are the
aggregates cleared during the resolution of peritonitis? (4)
Does resolution require exposure of CitH3+ DNA?
In sepsis, NETs promote a toxic inflammatory and procoagu-
lant host response to endotoxin (Martinod et al., 2015). However,
our data point toward an important role for omental NET release
to limit the propagation of contaminants from the peritoneal cav-
ity to the circulation. Due to constant drainage of peritoneal fluid
through FALCs and their high vascularization (Buscher et al.,
2016; Dickinson, 1906; Gray et al., 2012), FALCs are the main
portals for the systemic transit of peritoneal contaminants. Addi-
tional experiments are required to further investigate the effect of
PAD4 inhibition on neutrophil trafficking to secondary lymphoid
organs during peritonitis; altered neutrophil trafficking may influ-
ence the export of peritoneal contaminants through the draining
LNs and spleen. While targeted NET release on omFALCs is
beneficial during peritonitis, it may play a detrimental role in
ovarian cancer metastasis (Lee et al., 2019).
Resident peritoneal macrophages undergo a clotting
response within the first 2 h of contamination of the peritoneal
cavity, providing a means of clearing peritoneal contaminants
via coagulation and adhesion (Zhang et al., 2019). This mecha-
nism serves to convert fluid phase inflammation to a solid state
within the clots. Neutrophil aggregation within FALCs also en-
ables the conversion to a solid state, which is required for effi-
cient clearing of particles from the fluid phase. In doing so, neu-
trophils provide a timely relay for the neutralization of peritoneal
contaminants, since resident peritoneal macrophages are
rapidly sequestered in clots (Zhang et al., 2019). In gout and
pancreatitis, presence of high-density neutrophils in combina-
tion with the release of NETs leads to the formation of large
DNA aggregates. In gout, these aggregated NETs have the abil-
ity to degrade cytokines and chemokines via serine proteases
and may be important to limit inflammation (Schauer et al.,
2014). In pancreatitis, PAD4mediates the release of NETs, which
cause neutrophil aggregation and occlusion of pancreatic ducts(Leppkes et al., 2016). Aggregated NETs have been implicated in
the formation of gallstones (Mun˜oz et al., 2019); Mun˜oz et al.
report that uptake of small crystals results in NET release that
is dependent upon PAD4. Here, we show that omFALCs are
also sites where high densities of actively phagocytosing neutro-
phils aggregate in a PAD4-dependent mechanism during
peritonitis.
Previous studies have posited that both MPO and NE are
necessary for the release of bona fide NETs (Metzler et al.,
2011; Papayannopoulos et al., 2010). Here, we found that the
release of CitH3+ DNA and aggregation of neutrophils over the
surface of expanded omFALCs during peritonitis occurred
even in the absence of NE, suggesting a mechanism of DNA
release that did not conform to the same rules as classical NET
formation. In addition, CitH3+ DNA did not robustly co-localize
with MPO staining, again indicating a non-classical mechanism
of neutrophil CitH3+ DNA release. In contrast to NE, the forma-
tion of omFALC neutrophil aggregates was dependent upon
PAD4. Taken together, our findings contribute to mounting evi-
dence that mechanisms of NET release vary, dependent upon
context and location (Boeltz et al., 2019).
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Escherichia coli K12 bioparticles Invitrogen E13231
mCherry Escherichia coli Amarh et al., 2018 N/A
Zymosan-A S. cerevisiae bioparticles fluorescein
conjugate
Invitrogen Z8241
Zymosan-A S. cerevisiae Sigma Z4250
Biological Samples
Human blood, omentum & peritoneal washings Royal Infirmary of Edinburgh,
NHS Lothian
2016/0035
Chemicals, Peptides, and Recombinant Proteins
40,6-diamidino-2-phenylindole Sigma D9542
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Collagenase I Worthington CLS-1
Collagenase D Roche 11088858001
GSK484 Cayman chemicals 17488
Critical Commercial Assays
Chromium Single Cell 30 library and gel bead kit (v2) 10X Genomics 120267
High capacity cDNA Reverse Transcription Kit Applied Biosystems 4368814
LEGENDplex Human Inflammation Panel Biolegend 740879
LEGENDplex Human Pro-inflammatory Chemokine Biolegend 740003
LEGENDplex Mouse Pro-inflammatory chemokine
panel
Biolegend 740451
LIVE/DEAD Fixable Blue Dead Cell Stain Kit Invitrogen L23105
NovaSeq 6000 S1 Reagent Kit Illumina 20012864
RNeasy plus micro Kit QIAGEN 74034
ToxinSensorTM Chromogenic LAL Endotoxin Assay Kit Genscript L00350
Triton X-100 Sigma X100
SYTOX Blue nucleic acid stain Invitrogen S11384
Deposited Data
scRNaseq dataset GEO GSM4053741
Experimental Models: Organisms/Strains
Mouse: C57BL/6JOlaHsd Bred in house at University of
Edinburgh animal facilities
N/A
Mouse: Elane/ (C57BL/6J) Belaaouaj et al., 1998 N/A
Oligonucleotides
Cxcl1 Taqman gene expression assay Thermofisher Mm04207460_m1
Gapdh Taqman gene expression assay Thermofisher Mm9999995_g1
Software and Algorithms
FlowJo 10 FLOWJO, LLC https://www.flowjo.com
Prism 7 GraphPad Software https://www.graphpad.com/scientific-software/
prism
Fiji ImageJ https://imagej.net/Fiji
R The R Foundation www.r-project.org
Scmap version 1.8.0 Kiselev et al., 2018 https://bioconductor.org/packages/release/bioc/
html/scmap.html
Salmon version 0.14.1 Patro et al., 2017 https://github.com/COMBINE-lab/salmon/releases
DESeq2 Love et al., 2014 https://bioconductor.org/packages/release/bioc/
html/DESeq2.html
apeglm Zhu et al., 2019 https://bioconductor.org/packages/release/bioc/
html/apeglm.html
EnhancedVolcano version 1.4.0 Blighe and Lewis, 2019 http://bioconductor.org/packages/release/bioc/
html/EnhancedVolcano.html
slingshot Street et al., 2018 https://github.com/kstreet13/slingshot
Seurat R package version 3.1.1 Stuart et al., 2019 https://github.com/satijalab/seurat/releases/
tag/v3.1.1
Cell Ranger v3.0.2 Single-Cell Software Suite 10X Genomics https://support.10xgenomics.com/single-cell-
gene-expression/software/pipelines/latest/
installation
Bioreactome Fabregat et al., 2018 https://reactome.org
Huygens 19.0 software Scientific Volume Imaging https://svi.nl/Huygens-Software
LAS-X-3D Leica https://www.leica-microsystems.com/products/
microscope-software/p/leica-las-x-ls/downloads/
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RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Cecile
Benezech (cbenezec@ed.ac.uk)
Materials availability
This study did not generate new unique reagents
Data and Code Availability
The accession number for the scRNaseq dataset reported in this paper is GEO: GSM4053741. The authors declare that all relevant
data supporting the findings of this study are available on request. R scripts for performing the main steps of analysis are available
from the Lead contact on reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experimental animals
All experiments were conducted under a license granted by theHomeOffice (UK) that was approved by the University of Edinburgh or
Lancaster University animal welfare and ethics review board. All individual experimental protocols were approved by a named veter-
inarian surgeon prior to the start of the experiment. Experiments were performed using female C57BL/6 (C57BL/6JOlaHsd) or NE
deficient Elane/ mice (Belaaouaj et al., 1998) aged 8-12 weeks. All animals were bred and maintained under specific pathogen–
free conditions at the University of Edinburgh or Lancaster University Animal Facilities.
Human subjects
This study was approved by the Regional Research Ethics Committee (SE. Scotland REC 02; 16/SS/0042), the University of Edin-
burgh/NHS Lothian ACCORD R and D Office (ref: 2016/0035) and the Office of the Caldicott Guardian, NHS Lothian (patient confi-
dentiality advocate). Individuals were recruited after informed, signed consent was obtained. Clinical data (Table S1) and samples
were collected from patients undergoing laparoscopic surgery under general anesthesia for the following indications: biliary colic
and possible or suspected appendicitis, at the Royal Infirmary of Edinburgh between 1st April 2016 and 30th June 2018. After the in-
duction of anesthesia, a single tube of blood was collected into a BD Vacutainer prefilled by the manufacturer with the anticoagulant
EDTA. At operation, and as soon as practical and safe after the insertion of the laparoscopic ports (to avoid iatrogenic contamination
with blood), 25mL of sterile 0.154 M NaCl solution was washed into the area of interest and then aspirated using a sputum trap inter-
posed into the surgical suction equipment. Next a 5 cm3 sample of omentum was resected with scissors to avoid diathermy artifact,
retrieved and the sample site haemostasis ensured with diathermy. A 2 cm2 sample of parietal peritoneum adjacent to a port site was
obtained and haemostasis ensured. Operations then continued as planned. Clinical samples were handled as follows: omentum and
parietal peritoneum samples were collected into 20 mL of sterile dPBS (Sigma) within a 50ml tube. Peritoneal washings were placed
into a sterile 50ml tube. All patient samples were stored on wet ice or at 4C prior to collection from the clinical research facility and
transported to the research laboratory on foot, samples collected after 5pm were processed the following day. If there were any un-
expected findings at surgery, e.g., free peritoneal blood or peritoneal malignancy, patients were removed from the study and no tis-
sue samples were taken for research purposes. There were no adverse effects due to the research study conduct.
METHOD DETAILS
Peritonitis models
To induce peritonitis, mice were injected intra-peritoneally with either 0.5mg Zymosan-A (Sigma) in PBS, 0.25mg of Fluorescein
labeled Zymosan-A (Invitrogen), or PBS alone and samples were isolated 2-72 h later. To block NETosis, mice were injected i.p.
with 400 mg/mouse of GSK484 (Cayman Chemical). Blocking antibodies against CXCL1 (Clone 48415, Invitrogen) or isotype control
Rat IgG2a (Invitrogen) antibodies were injected i.p. 2 h after induction of peritonitis (40 mg/mouse). Following Zymosan and anti-
CXCL1 treatment, omenta were isolated and cultured with mCherry E. coli (Amarh et al., 2018) or E. coli bioparticles (Invitrogen)
in vitro for 5 min prior to thorough washing with RPMI-1640 (Sigma), and wholemount staining as described below.
Peritoneal exudate cells (PEC) were isolated by flushing murine peritoneal cavities with RPMI 1640 (Sigma). Murine omenta were
enzymatically digested with 1mg/mL Collagenase D (Roche) for 35 min at 37C in RPMI 1640 (Sigma) containing 1% Fetal Bovine
Serum (FBS) (Sigma). Spleens were mechanically disrupted using glass slides.
Human sample preparation
Human Omentum was weighed and 0.035 – 1.8g of tissue was digested using 2mg/mL Collagenase I (Worthington) in PBS (Invitro-
gen/sigma) 2% Bovine Serum Albumin (BSA, Sigma), samples were disrupted using an Octolyser (Miltenyi), incubated at 37C with
intermittent shaking for 45 min, subjected to a second Octolyser dissociation step, ions were chelated by addition of EDTA (0.5M,
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1700pm for 10 min. The cell pellet was resuspended in 2ml of PBS 2% BSA for flow-cytometric analysis. Peritoneal wash and blood
samples were centrifuged, the supernatant and serum were collected for further analysis and the cell pellet was resuspended for
flow-cytometric analysis. Cell numbers and live cell count were determined using a BioRad TC20 automated cell counter and
0.4% Trypan Blue (Sigma). For the omentum ex vivo culture, a small piece of omentum (between 0.02 and 0.06 g) was placed in cul-
ture in 1ml of RPMI 1640 (Sigma) 10% fetal bovine serum (Sigma) 2 mM L-glutamine (Sigma) for 2 h at 37C.
Flow cytometry
Murine cells were stained with LIVE/DEAD (Invitrogen), blocked with mouse serum and anti-murine CD16/32 (clone 2.4G2, Bio-
legend) and stained for cell surface markers. Human samples were blocked with serum, stained for cell surface markers (See Key
Resources Table for list of antibodies used), and DAPI (Sigma) was added to the cells prior to acquisition. All samples were acquired
using a BD Fortessa and analyzed with FlowJo software (FlowJo, LLC).
Cell-sorting and quantitative real-time PCR
Cells were stained for cell surface marker and sorted using a FACS Aria Fusion directly in 350 mL RLP buffer before RNA extraction
using RNeasy PlusMicro Kit (QIAGEN) according tomanufacturer’s instruction. Complementary DNA formRNA analysis was synthe-
sized from total RNAusingHighCapacity cDNAReverseTranscriptionKit (Appliedbiosystems).Cxcl1expressionwasassessedusing
TaqManGeneExpressionAssay (Mm04207460_m1) by qRT-PCR (Life Technologies) and normalized toglyceraldehyde-3-phosphate
dehydrogenase (Gapdh, Mm9999995_g1). The Ct ofGapdhwas subtracted from the Ct of Cxcl1, and the relative amount was calcu-
lated as 2DCt. Means of triplicate reactions were represented for n = 4 biological samples per condition from two separate sorts.
Detection of chemokines, cytokine, dDNA and LPS
dsDNA was detected in lavage fluid and omentum culture supernatants using the picogreen assay following the manufacturer’s in-
structions (Invitrogen). LPS was detected in human serum, omentum culture supernatants and peritoneal lavage fluid using the
ToxinSensorTM Chromogenic LAL Endotoxin Assay Kit (GenScript) following manufacturer’s instructions. Human Pro-inflammatory
chemokines and Human Inflammation Legendplex arrays (Biolegend) were used to detect cytokines and chemokines following the
manufacturer’s instructions. For the heatmap representation in Figure 7C, original values were scaled between 0 and the maximum
value detected for each cytokine and presented as a fraction of maximum secretion. Murine samples of omentum, mesenteries, pa-
rietal wall, diaphragm and liver were placed in culture for 2 h in 300 mL RPMI containing 10% FBS (Sigma) and 1% L-glutamine
(Sigma). The quantity of murine CXCL1, CCL2 and CXCL10 present within cell culture supernatants was determined using a mix
and match mouse pro-inflammatory chemokine Legendplex array (Biolegend) following the manufacturer’s instructions.
Immunofluorescence staining and microscopy
Human and mouse omentum samples were fixed for one h on ice in 10% NBF (Sigma) and then permeabilized in PBS 1% Triton
X-100 (Sigma) for 20 min at room temperature prior to staining with primary antibodies for one h at room temperature in PBS
0.5% BSA 0.5% Triton. After washing in PBS, tissues were stained with secondary antibodies for one h at room temperature in
PBS 0.5% BSA 0.5% Triton. For extra-cellular DNA staining, human omental tissues were first stained with SYTOX Blue (Invitrogen)
1 in 5000 in RPMI 1640 (Sigma) for 30 min at room temperature, washed in RPMI and then fixed in 10% NBF (Sigma) prior to per-
meabilization and staining. Antibodies used are listed in Key Resources Table. After mounting with Fluoromount G (Thermofisher),
confocal images were acquired using a Leica TCS SP5 or TCS SP8 laser scanning confocal microscope. Image analysis was per-
formed using Fiji and 3D reconstruction was created using LAS-X-3D (Leica). Themean gray value of MPO, Ly6G, CitH3 andmCherry
E. coli was calculated inside a perimeter delimited manually as the border of the cluster. To calculate FALC volume, we manually
assessed the maximum length, width and depth (z) of the clusters visualized with DAPI using 10x objective while scanning on
SP5 confocal microscope. To calculate the area of FALCs covered by E. coli, the perimeter of the FALC was delimited manually
and a fixed threshold for E.coli fluorescence was set. The number of CitH3+ nuclei and E. coli bioparticles was calculated using
the ‘‘analyse particles’’ function of Fiji. The large picture of the omentum was taken as stack on a Zeiss Axio Observer Z1, decon-
volved using the SVI Huygens 19.0 software and processed in Fiji first using theMaximum Intensity Projection and then stitched using
Grid/Collection stitching (Preibisch et al., 2009).
Droplet based scRNaseq and data pre-processing
Immediately post-sorting, DAPI-CD45-Ter119-CD41-CD31- stromal cell pooled from the omenta from three naive mice were run on
the 10X chromium (10X Genomics) and then through library preparation following the recommended protocol for the Chromium Sin-
gle Cell 30 Reagent Kit (v2). Libraries were run on the NovaSeq S1for Illumina sequencing. Sequence reads were processed using the
Cell Ranger v3.0.2 Single-Cell Software Suite from 10x Genomics. Reads were aligned to the mm10 mouse references genome
(Ensembl 93). As a quality control step, genes were excluded if they were expressed in fewer than three cells. Cells were excluded
on a number of criteria: those with fewer than 300 genes (n = 13), those with fewer than 300 or greater than 16000 UMIs (n = 21) or
those with mitochondrial gene proportion of over 20%of total UMI counts (n = 14). A global normalization was performed where gene
expression was normalized for each cell based on its total expression before being multiplied by a scale factor of 10,000 and log
transformed. Variation in the UMI counts of each cell was regressed using a linear regression. Residuals from this model were
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gene. A list of 2000 variable genes were generated using the ‘vst’ method of the FindVariableFeatures function from the Seurat R
package version 3.1.1 (Stuart et al., 2019). We obtained the transcriptional profile of 4,501 cells that passed quality control and
filtering, for which we measured a median of 2,214 genes per cell.
scRNaseq data analysis and visualization
Dimensionality reduction, unsupervised clustering and differential gene expression were performed using Seurat.We used between
1 and 10 principal components for shared nearest neighbor (SNN) clustering, as determined by the dataset variability shown in the
principle component analysis (PCA). The resolution parameter was optimized based on the number of resulting clusters. Clusters
were initially categorised into cell lineages based on expression of knownmarker genes. Clusters annotated as endothelial (Pecam1,
Cdh5), immune (Ptprc), proliferating (Mki67, Pcna, Top2a) or those with amedian number of genes per cell below 1000were excluded
from further analysis. The final dataset contained 3,838 cells measuring a median of 2,249 genes per cell. Variable features and
scaled expression were re-calculated for the refined dataset, followed by dimensionality reduction and re-clustering using the
same methodology described above. Differential gene expression analysis was conducted using the FindAllMarkers function of
Seurat and a Wilcox rank sum test (Table S3). Only genes with at least a 0.25 log-fold change and expressed in at least 25% of
the cells in the cluster under comparison were evaluated. The FindMarkers function was used for direct cluster-to-cluster comparison
using the same statistical model and thresholds. Cluster similarity was assessed using the BuildClusterTree function of Seurat. All
violin plots, UMAP visualizations and heatmaps were generated using functions from Seurat, ggplot2, pheatmap, and grid R pack-
ages. UMAPs were constructed using the same number of principle components as the corresponding clustering. Heatmaps were
generated using scaled expression and their range was clipped from 2.5 to 2.5. DEGs from each cluster were used for pathway
analysis using Bioreactome (Fabregat et al., 2018)
Mesothelium trajectory inference
We generated a subset of the data including clusters ‘‘Cxcl13+mesothelium,’’ ‘‘Ifit+mesothelium,’’ and ‘‘Mesothelium,’’ re-scaled the
expression data, and performed PCA analysis followed by pseudotime analysis in slingshot (Street et al., 2018). Lineage inference
was performed using a cluster-based minimum spanning tree on PCs 1:10, specifying ‘‘Mesothelium’’ as the starting cluster. Pseu-
dotime values thus generated weremapped to the previously generated UMAP for visualization. Variable genes of the subsetted data
were then regressed on the resulting pseudotime variables using a general additive model to identify those genes that are differen-
tially expressed across pseudotime. Cubic smoothing spline curves were fitted to the scaled expression of a selection of the top 50
differentially expressed genes (p value < 1e-16) along the pseudotemporal trajectory using the smooth.spline (df = 3) command from
the R stats package. These results were plotted as a heatmap with the range clipped from 2 to 2.
Mapping mesenteric single cell data
The processed single cell mesenteric dataset was downloaded fromGEO: GSE102665 (Koga et al., 2018). Cell filtering, normalization
and dimensionality reduction from the omentum scRNaseq data analysis (as above) were replicated on the mesenteric scRNaseq
data. Pdgfra+Pdpn- and Pdgfra+Pdpn+ clusters were identified, isolated and mapped individually to the omentum dataset using
Scmap version 1.8.0 (Kiselev et al., 2018), following instructions given in the package vignette for feature selection and indexing
of the omentum data, and cluster mapping.
RNaseq data analysis
RNaseq data for epididymal adipose mesothelial cells was downloaded from GEO: GSM3754627, GSM3754628, GSM3754629.
RNaseq data for omentum mesothelial cells was downloaded from GEO: GSM3754642, GSM3754643, GSM3754644 (Buechler
et al., 2019). We used Salmon version 0.14.1 (Patro et al., 2017) to align and quantify transcripts to the GRCm38 reference transcrip-
tome (ensemble 81) with ‘‘validateMappings,’’ ‘‘seqBias,’’ and ‘‘gcBias’’ options enabled. This data was imported into R using the
tximeta package (citation), and genes with a count level of 1 or less were removed. DESeq2 (Love et al., 2014) was used to perform
differential gene expression analysis between the omentum and epididymal samples with an adjusted p value cutoff set to 0.05 for a
log fold change threshold of 0. Log-fold change shrinking was performed using the apeglmmethod (Zhu et al., 2019) before plotting a
volcano plot in EnhancedVolcano version 1.4.0 (Blighe and Lewis, 2019) where y axis (-log10 adjusted P) were clipped to 50.
QUANTIFICATION AND STATISTICAL ANALYSIS
No randomization and no blinding was used for the animal experiments. Whenever possible, the investigator was partially blinded for
assessing the outcome (bacterial binding). All data were analyzed using Prism 7 (GraphPad Prism, La Jolla, CA). Statistical tests per-
formed, sample size and number of repetitions for each dataset, are described within the relevant figure legend.Immunity 52, 700–715.e1–e6, April 14, 2020 e6
